IDXAF (IDEX Biometrics ASA) Cyclically Adjusted Revenue per Share: $0.17 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IDXAF IDEX Biometrics ASA IDXAF
26 GF Score
Price $0.89
GF Value $0.01
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is IDEX Biometrics ASA Cyclically Adjusted Revenue per Share?

IDEX Biometrics ASA IDXAF 26 Cyclically Adjusted Revenue per Share is $0.17 as of Mar. 2026. GuruFocus rates IDXAF with a GF Score™ of 26/100 and a GF Value™ of $0.01 (Significantly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

IDEX Biometrics ASA's adjusted revenue per share for the three months ended in Mar. 2026 was $0.003. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.17 for the trailing ten years ended in Mar. 2026.

During the past 12 months, IDEX Biometrics ASA's average Cyclically Adjusted Revenue Growth Rate was 3.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 16.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of IDEX Biometrics ASA was 24.50% per year. The lowest was -7.00% per year. And the median was 12.75% per year.

As of today (2026-07-17), IDEX Biometrics ASA's current stock price is $0.89. IDEX Biometrics ASA's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $0.17. IDEX Biometrics ASA's Cyclically Adjusted PS Ratio of today is 5.24.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of IDEX Biometrics ASA was 448.54. The lowest was 0.33. And the median was 85.02.


IDEX Biometrics ASA  (OTCPK:IDXAF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

IDEX Biometrics ASA's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.89/0.17
=5.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of IDEX Biometrics ASA was 448.54. The lowest was 0.33. And the median was 85.02.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


IDEX Biometrics ASA Cyclically Adjusted Revenue per Share Related Terms


IDEX Biometrics ASA Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for IDEX Biometrics ASA's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDEX Biometrics ASA Cyclically Adjusted Revenue per Share Chart

IDEX Biometrics ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.12 1.03 0.80 0.02 0.27

IDEX Biometrics ASA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.52 0.00 0.27 0.17

IDXAF vs UBER, SHOP, CRM: Cyclically Adjusted Revenue per Share Comparison

For the Software - Application subindustry, IDEX Biometrics ASA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDEX Biometrics ASA Cyclically Adjusted PS Ratio vs Software Industry

For the Software industry and Technology sector, IDEX Biometrics ASA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where IDEX Biometrics ASA's Cyclically Adjusted PS Ratio falls into.


IDXAF
26GF Score
IDEX Biometrics ASA IDXAF
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IDEX Biometrics ASA Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, IDEX Biometrics ASA's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.003/141.0300*141.0300
=0.003

Current CPI (Mar. 2026) = 141.0300.

IDEX Biometrics ASA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.864 103.800 1.174
201609 0.489 104.200 0.662
201612 0.681 104.400 0.920
201703 0.361 105.000 0.485
201706 0.257 105.800 0.343
201709 0.213 105.900 0.284
201712 0.069 106.100 0.092
201803 0.027 107.300 0.035
201806 0.017 108.500 0.022
201809 0.060 109.500 0.077
201812 0.109 109.800 0.140
201903 0.004 110.400 0.005
201906 0.017 110.600 0.022
201909 0.051 111.100 0.065
201912 0.025 111.300 0.032
202003 0.036 111.200 0.046
202006 0.060 112.100 0.075
202009 0.095 112.900 0.119
202012 0.167 112.900 0.209
202103 0.177 114.600 0.218
202106 0.249 115.300 0.305
202109 0.252 117.500 0.302
202112 0.197 118.900 0.234
202203 0.237 119.800 0.279
202206 0.326 122.600 0.375
202209 0.279 125.600 0.313
202212 0.885 125.900 0.991
202303 0.266 127.600 0.294
202306 0.287 130.400 0.310
202309 0.216 129.800 0.235
202312 0.102 131.900 0.109
202403 0.053 132.600 0.056
202406 0.138 133.800 0.145
202409 0.019 133.700 0.020
202412 0.005 134.800 0.005
202503 0.007 136.100 0.007
202506 0.003 137.800 0.003
202509 0.000 138.500 0.000
202512 0.001 139.100 0.001
202603 0.003 141.030 0.003

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $0.17 mean?
IDEX Biometrics ASA (IDXAF) has a Cyclically Adjusted Revenue per Share of $0.17 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on IDEX Biometrics ASA and its competitors.
Is IDEX Biometrics ASA's Cyclically Adjusted Revenue per Share too high?
IDEX Biometrics ASA's current Cyclically Adjusted Revenue per Share is $0.17. Overall, IDEX Biometrics ASA has a GF Score™ of 26/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IDEX Biometrics ASA's Cyclically Adjusted Revenue per Share compare to UBER and SHOP?
IDEX Biometrics ASA's Cyclically Adjusted Revenue per Share of $0.17 can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Software company?
A good Cyclically Adjusted Revenue per Share depends on the Software industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on IDEX Biometrics ASA and its competitors. IDEX Biometrics ASA's current Cyclically Adjusted Revenue per Share is $0.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDEX Biometrics ASA stock overvalued right now?
Based on GuruFocus' analysis, IDEX Biometrics ASA (IDXAF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.01, compared to a current price of $0.89 — trading 8800% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is $0.17. IDEX Biometrics ASA's overall GF Score™ is 26/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For IDEX Biometrics ASA (IDXAF), the current Cyclically Adjusted Revenue per Share is $0.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IDEX Biometrics ASA (IDXAF) Overvalued in 2026?

Based on GuruFocus' analysis, IDEX Biometrics ASA stock appears to be overvalued. The current stock price of $0.89 is trading 8800% above its estimated GF Value™ of $0.01. GuruFocus considers IDEX Biometrics ASA to be Significantly Overvalued.

Key valuation signals for IDXAF:

  • Cyclically Adjusted Revenue per Share: $0.17
  • GF Value™: $0.01 vs. price of $0.89 (8800% above fair value)
  • GF Score™: 26/100 with 5 warning signs

No single metric tells the full story. See the IDXAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IDEX Biometrics ASA Business Description

Address Henrik Ibsens gate 90, Oslo, NOR, 0255
IDEX Biometrics ASA develops and manufactures fingerprint biometric cards for access control, digital identity, and payment. Its products use fingerprint biometrics for user authentication and are designed for physical and digital access applications. The company serves banks, enterprises, and public sector organizations through direct sales and channel partners.
26GF Score

Get the complete analysis for IDXAF

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.89
Price
$0.01
GF Value